Neurometrix Inc news

   Watch this stock
Showing stories 1 - 10 of about 14   

Articles published

NURO 2.27 -0.05 (-2.16%)
price chart
NeuroMetrix, Inc. Announces Date for 2014 First Quarter Financial Results ...
WALTHAM, Mass., Apr 16, 2014 (BUSINESS WIRE) -- NeuroMetrix, Inc. (the �Company�) (NASDAQ:NURO) , an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage ...
NeuroMetrix Inc.: NeuroMetrix, Inc. Announces Date for 2014 First Quarter ...
WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve ...
Related articles »  
NeuroMetrix Reports First Quarter 2014 Financial Results and Business Highlights
NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today ...
Related articles »  
NeuroMetrix Initiates Patient-Focused Program for Early Detection of Diabetic ...
WALTHAM, Mass., Apr 01, 2014 (BUSINESS WIRE) -- NeuroMetrix, Inc. (the �Company�) (NASDAQ:NURO) , an innovative health care company that develops wearable medical technology and point-of-care diagnostics that helps patients and physicians ...
Related articles »  
Stocks to Track: NeuroMetrix(NURO), NURO, Groupon (GRPN), GRPN, Ocean ...
Neurometrix Inc (NASDAQ:NURO) opened the session at $2.49, trading in a range of $2.41 to $2.49, and closed at $2.46. The stock showed a negative performance of -0.81% in the last trading session.
Related articles »  
Most Volatile Stocks: NeuroMetrix (NURO), Gogo's (GOGO), MGT Capital (MGT ...
Neurometrix Inc (NASDAQ:NURO) opened the session at $2.34, trading in a range of $2.34 to $2.48, and closed at $2.48. The stock showed a positive performance of 5.98% in the last trading session.
The Top Life Sciences Investors Of 2014
Recent additions to Byers' collection of exits are VeraCyte Inc. (IPO 2013), Foundation Medicine Inc. (IPO 2013), Five Prime Therapeutics Inc. (IPO 2013), Pacific Biosciences of California Inc. (IPO 2010), OptiMedica Corp. (acquired by Abbott ...
Related articles »  
Direct Global Media Re-Initiates Coverage on EKO International (EKNL) and ...
(EKNL) and provides further update on their featured Cannabis and Medical Marijuana Company, HEMP Inc. (HEMP). Sign-up for Direct Global Media's Free Research ... "Since we first initiated coverage of EKO International, the company had built ...
(Menafn - Marketwired via COMTEX)  MENAFN.COM
Related articles »